IMAB

Q: What is the price of I-Mab (IMAB) today?

The price of I-Mab (IMAB) today is $ 3.99, with return of 299% compared to the last year. The price of I-Mab (IMAB) started the year trading around $ 0.85 and today it is at $ 3.99. Follow the real-time price chart, the historical price of I-Mab (IMAB) and international markets.

Q: When does I-Mab (IMAB) pay dividends?

I-Mab (IMAB) did not distribute dividends in the last year.

Q: Is I-Mab (IMAB) worth it?

Currently, I-Mab (IMAB) is priced at $ 3.99, with a P/E of -9.06%, representing a deviation of 258% from its historical average P/E. In the last year, the stock showed a variation of 299 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 299.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy I-Mab (IMAB) stock?

Investing in stocks of I-Mab (IMAB) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of I-Mab (IMAB) yield today?

The yield of I-Mab (IMAB) was -3.62% in the last month, 299.00% in the last year and -89.97% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of I-Mab (IMAB) today, the total investment would be $ 399.00, based on the current price of $ 3.99.If past performance were to repeat, the return on your investment would be:In 1 year: $ 1,592.01In 5 years: $ 40.02In 10 years: $ 399.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

I-Mab

Price

$ 3.99

return (12m)

299.00%

p/e

-9.06

p/bv

1.76

DIVIDEND YIELD

0.00%

price IMAB

IMAB

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of IMAB

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-3.62%

3 months

-2.44%

1 year

299.00%

2 years

162.50%

5 years

-89.97%

10 years

0.00%

Fundamentals IMAB

review the fundamentals of I-Mab shares

P/E

-9.06

Sector: -3.74 Industry: -3.74

P/SALES RATIO (PSR)

Sector: -3.71 Industry: -3.71

P/BV

1.76

Sector: 2.05 Industry: 2.05

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-18.48%

Sector: -63.91% Industry: -63.91%

ROE

-19.42%

Sector: -67.36% Industry: -67.36%

ROIC

-74.43%

Sector: -1,129.15% Industry: -1,129.15%

NET MARGIN

0.00%

Sector: -41.63% Industry: -41.63%

GROSS MARGIN

0.00%

Sector: 39.39% Industry: 39.39%

OPERATING MARGIN

0.00%

Sector: -41.51% Industry: -41.51%

P/EBITDA

-9.38

Sector: -3.78 Industry: -3.78

P/EBIT

-9.38

Sector: -3.91 Industry: -3.91

P/ASSET

1.67

Sector: 1.49 Industry: 1.49

BVPS

2.40

Sector: 1.73 Industry: 1.73

EPS

-0.47

Sector: -2.05 Industry: -2.05

EQUITY RATIO

0.95

Sector: 0.41 Industry: 0.41

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

Fundamentals IMAB

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	20.28	0.00	0.00%	2.43%	$ 509.48 B	27.26%
PFE	14.95	1.58	10.56%	6.65%	$ 146.96 B	15.65%
ABBV	168.68	-154.98	-91.88%	2.88%	$ 402.80 B	4.00%
NVO	14.47	8.35	57.70%	3.36%	$ 223.00 B	32.78%
MRK	13.16	0.00	0.00%	3.23%	$ 250.55 B	29.63%
AZN	29.65	6.06	20.45%	1.74%	$ 278.65 B	16.17%
BMY	17.67	5.74	32.47%	4.73%	$ 106.71 B	12.57%
GILD	18.45	6.98	37.80%	2.61%	$ 149.66 B	27.88%
ZTS	19.83	9.74	49.11%	1.69%	$ 52.57 B	28.21%
HALO	12.22	14.44	118.17%	0.00%	$ 7.28 B	47.91%
REGN	16.84	2.49	14.79%	0.47%	$ 77.09 B	32.13%
AMGN	24.40	17.77	72.82%	3.00%	$ 170.94 B	19.47%
VRTX	31.49	6.68	21.22%	0.00%	$ 115.72 B	31.35%
MCK	25.02	-174.59	-697.75%	0.36%	$ 100.91 B	1.04%
CAH	29.57	-17.27	-58.40%	1.03%	$ 47.17 B	0.68%
ADMA	22.57	10.96	48.57%	0.00%	$ 4.73 B	42.87%
BIIB	15.91	1.41	8.83%	0.00%	$ 25.59 B	15.98%
HRMY	12.65	2.81	22.24%	0.00%	$ 2.35 B	22.48%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

IMAB Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY I-Mab

I-Mab

Average user rating I10

4.0 (5 people)

United States

9 years

Founded: 2016

2020

Time since IPO - 5 years

228

Employees

The Company I-Mab (United States), is listed on Nasdaq with a market value of $ 346.04 Millions, having an equity of $ 196.73 Millions.

With a total of 228 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -38.20 Millions.

As for its main indicators, the Company has a P/E ratio of -9.06, a P/BV ratio of 1.76 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker IMAB.

Market cap

$ 346.04 Millions

Net worth

$ 196.73 Millions

US$ 196,730,000.00

Assets

$ 206.71 Millions

US$ 206,710,000.00

Total Shares Outstanding

82.00 Millions

82,000,000

Average Daily Trading Volume

$ 1.90 Million

US$ 1,899,324.88

Sector

Health Care

Industry

Biotechnology

IMAB

IMAB revenue and profits

Financial Results IMAB

DRAG THE FRAME TO SEE MORE DATA

IMAB cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 813.80 41,85% (12M)

P/E

25.02

0.36%

ROE

-697.75%

P/BV

-174.59

CAH - Cardinal Health

$ 198.18 70,22% (12M)

P/E

29.57

1.03%

ROE

-58.40%

P/BV

-17.27

JNJ - Johnson & Johnson

$ 211.58 48,72% (12M)

P/E

20.28

2.43%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 100.30 1,98% (12M)

P/E

13.16

3.23%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.85 9,78% (12M)

P/E

14.95

6.65%

ROE

10.56%

P/BV

1.58

ABBV - AbbVie

$ 223.32 34,34% (12M)

P/E

168.68

2.88%

ROE

-91.88%

P/BV

-154.98

AZN - AstraZeneca

$ 89.83 37,80% (12M)

P/E

29.65

1.74%

ROE

20.45%

P/BV

6.06

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 813.80 41,85% (12 M)

P/L

25.02

0.36%

ROE

-697.75%

P/VP

-174.59

CAH - Cardinal Health

$ 198.18 70,22% (12 M)

P/L

29.57

1.03%

ROE

-58.40%

P/VP

-17.27

JNJ - Johnson & Johnson

$ 211.58 48,72% (12 M)

P/L

20.28

2.43%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 100.30 1,98% (12 M)

P/L

13.16

3.23%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.85 9,78% (12 M)

P/L

14.95

6.65%

ROE

10.56%

P/VP

1.58

ABBV - AbbVie

$ 223.32 34,34% (12 M)

P/L

168.68

2.88%

ROE

-91.88%

P/VP

-154.98

AZN - AstraZeneca

$ 89.83 37,80% (12 M)

P/L

29.65

1.74%

ROE

20.45%

P/VP

6.06

Frequently Asked Questions

What is the price of I-Mab (IMAB) today?

The price of I-Mab (IMAB) today is $ 3.99, with return of 299% compared to the last year. The price of I-Mab (IMAB) started the year trading around $ 0.85 and today it is at $ 3.99. Follow the real-time price chart, the historical price of I-Mab (IMAB) and international markets.

When does I-Mab (IMAB) pay dividends?

I-Mab (IMAB) did not distribute dividends in the last year.

Is I-Mab (IMAB) worth it?

Currently, I-Mab (IMAB) is priced at $ 3.99, with a P/E of -9.06%, representing a deviation of 258% from its historical average P/E. In the last year, the stock showed a variation of 299 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 299.00%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy I-Mab (IMAB) stock?

Investing in stocks of I-Mab (IMAB) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of I-Mab (IMAB) yield today?

The yield of I-Mab (IMAB) was -3.62% in the last month, 299.00% in the last year and -89.97% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of I-Mab (IMAB) today, the total investment would be $ 399.00, based on the current price of $ 3.99.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 1,592.01
In 5 years: $ 40.02
In 10 years: $ 399.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

IMAB

I-Mab

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of IMAB

review the fundamentals of I-Mab shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY I-Mab

I-Mab

United States

9 years

2020

228

PROFIT X PRICE IMAB

Financial Results IMAB

IMAB cash flow

asset growth - IMAB

IMAB balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions